常规剂量替罗非班联合半剂量瑞替普酶在ST段抬高性急性心肌梗死治疗中的临床效果

段鸿建

（陕西省康复医院急诊科，陕西 西安，710065）

浏览次数：102次 下载次数：396次

摘要：

目的 探究常规剂量的替罗非班与半剂量瑞替普酶联合治疗ST 段抬高性急性心肌梗死的临床效果。方法 选取在我院就诊的ST段抬高性急性心肌梗死患者96 例为研究对象，根据治疗方法不同分为观察组和对照组，每组48 例。对照组患者 给予常规剂量瑞替普酶治疗，观察组患者给予常规剂量替罗非班联合半剂量瑞替普酶治疗。比较两组患者的血管再通率、并发症发生率、神经功能缺损程度。结果 观察组患者溶栓治疗30、60、120 min 时的血管再通率均明显高于对照组，且随着溶栓 治疗时间的延长，两组患者的血管再通率均明显提高（P<0.05）；观察组患者的并发症总发生率（10.42%）略低于对照组的（12.49%）（P>0.05）；治疗2 h 时，两组患者NIHSS 评分均显著降低，且观察组明显低于对照组（P<0.05）。结论 对ST 段抬高性 急性心肌梗死患者应用常规剂量替罗非班联合半剂量的瑞替普酶治疗效果确切，有助于促进血管再通，值得推广应用。

关键词：替罗非班；瑞替普酶；ST 段抬高性急性心肌梗死

中图分类号：R542.2文献标志码：A文章编号：2096-1413(2017)34-0018-02

Clinical effect of conventional dose of tirofiban combined with half dose of reteplase in the treatment of ST-segment

elevation acute myocardial infarction
DUAN Hong-jian
(Emergency Department, Shaanxi Kangfu Hospital, Xi``an 710065, China)

ABSTRACT: Objective To investigate the clinical effect and safety of conventional dose of tirofiban combined with half dose of remifetil in the treatment of ST-segment elevation acute myocardial infarction. Methods A total of 96 patients with ST-segment elevation acute myocardial infarction admitted in our hospital were selected and divided into treatment group and control group according to the different treatment methods, with 48 cases in each group. The control group was given conventional dose reteplase, and the observation group was treated with conventional dose of tirofiban combined with half dose of reteplase. The recanalization rate, incidence of complications and neurological deficit degree were compared between the two groups. Results The recanalization rates in the observation group were significantly higher than those in the control group at 30, 60 and 120 min after treatment, and as the extension of thrombolysis treatment time, the recanalization rates in the two groups significantly improved (P<0.05). The total incidence rate of complications in the observation group was 10.42%, which was slightly lower than 12.49% in the control group (P>0.05). At 2 h after the treatment, the NIHSS scores in the two groups significantly decreased, and that in the observation group was lower than the control group (P<0.05). Conclusion The conventional dose of tirofiban combined with half dose of reteplase is effective in patients with ST -segment elevation acute myocardial infarction, it is conducive to revascularization, which worthy of promotion and application.
KEYWORDS: tirofiban; reteplase; ST-segment elevation acute myocardial infarction

参考文献：
[1] 戴树人,李芝峰,廖荣宏,等.替罗非班联合瑞替普酶在ST 段抬高性 急性心肌梗死中的疗效观察[J].重庆医学,2014,43(21):2720-2721.
[2] 赵玉勤,何家富,李彬,等.瑞替普酶联合替罗非班对老年急性心肌 梗死患者微循环及凝血状态的影响[J].海南医学院学报,2014,20(11):1496-1498.
[3] 邹军锋.瑞替普酶联合替罗非班在老年急性心肌梗死中的溶栓效 果与安全性观察[J].海南医学院学报,2014,20(10):1326-1327,1330.
[4] 王庭学,吴国平,梁毓源,等.常规剂量替罗非班联合半剂量瑞替普 酶对急性STEMI 的疗效[J].心血管康复医学杂志,2016,25(3):308-311.
[5] 耿巍,傅向华,田祥,等.瑞替普酶溶栓成功后早期冠状动脉介入治疗的安全性及有效性研究[J].中国介入心脏病学杂志,2013,21(5):310-314.
[6] 郑爱娣,王咏梅,徐静,等.大剂量与常规剂量氯吡格雷联合替罗非 班治疗急性心肌梗死的对比研究[J].临床药物治疗杂志,2014,12(2):40-42.
[7] 杨秋菊.大剂量他汀联合替罗非班治疗急性心肌梗死的临床疗效 [J].中国伤残医学,2016,19(1):96-97.